AngioDynamics to Present at Three Investor Conferences in March

LATHAM, N.Y.--(BUSINESS WIRE)--AngioDynamics, Inc. (NASDAQ: ANGO), a leading provider of innovative, minimally invasive medical devices for vascular access, peripheral vascular disease, and oncology, today announced that Jim Clemmer, President and Chief Executive Officer, and Stephen Trowbridge, Executive Vice President and Chief Financial Officer, will present at the following three investor conferences in March:

Conference: Oppenheimer Virtual Healthcare Conference
Date: Tuesday, March 15, 2022
Presentation: 8:40 a.m. ET

Conference: Barclays Global Healthcare Conference
Location: Miami Beach, FL
Date: Wednesday, March 16, 2022
Presentation: 9:00 a.m. ET

Conference: KeyBanc Virtual Life Sciences & MedTech Investor Forum
Date: Tuesday, March 22, 2022
Presentation: 3:45 p.m. ET

A live webcast of each presentation will be accessible through the “Investors” section of the Company’s website at www.angiodynamics.com and will be available for replay following each event.

About AngioDynamics, Inc.

AngioDynamics, Inc. is a leading provider of innovative, minimally invasive medical devices used by professional healthcare providers for vascular access, peripheral vascular disease, and oncology. AngioDynamics’ diverse product lines include market-leading ablation systems, vascular access products, angiographic products and accessories, drainage products, thrombolytic products, and venous products. For more information, visit www.angiodynamics.com.

Investor Contact:

AngioDynamics, Inc.
Stephen Trowbridge, Executive Vice President & CFO
(518) 795-1408